Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction
Status:
Completed
Trial end date:
2004-08-30
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this study is to assess patient satisfaction
after switching to biphasic human insulin 30 treatment using the NovoLet® insulin device as
treatment for diabetes mellitus under normal clinical practice setting.